VERACYTE, INC. (21)
Browse by Contract Category
Contracts
-
Form of stock unit award agreement
(Filed With SEC on November 2, 2020)
-
Offer Letter dated as of August 9, 2011 with John Hanna
(Filed With SEC on February 25, 2020)
-
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between John Hanna and the Registrant
(Filed With SEC on July 30, 2019)
-
Diagnostic Development Agreement, dated December 28, 2018, between Johnson & Johnson Services, Inc. and the Registrant
(Filed With SEC on February 25, 2019)
-
Form of stock option award agreement
(Filed With SEC on November 2, 2020)
-
Underwriting Agreement dated August 4, 2020
(Filed With SEC on August 5, 2020)
-
Enrollment Form for the Amended and Restated Employee Stock Purchase Plan
(Filed With SEC on July 30, 2020)
-
Amended and Restated Employee Stock Purchase Plan
(Filed With SEC on June 9, 2020)
-
Offer Letter dated as of March 5, 2008 with Giulia Kennedy
(Filed With SEC on February 25, 2020)
-
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on February 25, 2020)
-
Registration Rights Schedule, dated December 3, 2019
(Filed With SEC on December 3, 2019)
-
License and Asset Purchase Agreement, dated December 3, 2019, by and among Veracyte, Inc. and NanoString, Inc
(Filed With SEC on December 3, 2019)
-
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Giulia Kennedy and the Registrant
(Filed With SEC on July 30, 2019)
-
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Keith Kennedy and the Registrant
(Filed With SEC on July 30, 2019)
-
Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Bonnie Anderson and the Registrant
(Filed With SEC on July 30, 2019)
-
Services and Separation Agreement, effective April 22, 2019 between Chris Hall and the Registrant
(Filed With SEC on July 30, 2019)
-
Underwriting Agreement dated May 2, 2019
(Filed With SEC on May 3, 2019)
-
Agreement dated as of October 16, 2017, between Thyroid Cytopathology Partners, P.A. and the Registrant, as amended
(Filed With SEC on April 30, 2019)
-
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Keith Kennedy and the Registrant
(Filed With SEC on February 25, 2019)
-
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Christopher Hall and the Registrant
(Filed With SEC on February 25, 2019)
-
Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Bonnie Anderson and the Registrant
(Filed With SEC on February 25, 2019)